Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.
Rates of liver complications were similar, but HIV-positive people had more non-liver cancers and non-liver-related deaths.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
Curing the virus was associated with a lower risk of liver cancer recurrence.
What’s more, such treatment is linked to remission of non–Hodgkin lymphoma.
A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco
Among a large group treated with minimal or no liver fibrosis, liver-health problems were almost nonexistent up to three years later.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.